DEE-INX 60 is a proton pump inhibitor used in acid-related gastrointestinal disorders. It provides prolonged acid suppression and symptom relief.
The formulation is effective in GERD, esophagitis, and gastric ulcers, supporting healing of the gastric mucosa.
Well suited for long-term acid control, DEE-INX 60 offers advanced dual-release therapy for sustained acid management under medical guidance.
Provides effective relief in non-erosive gastro-esophageal reflux disease (GERD) with improved symptom control.
Provides effective relief in non-erosive gastro-esophageal reflux disease (GERD).
Dual delayed-release mechanism ensures extended acid control throughout the day and night.
Helps reduce heartburn, epigastric pain, regurgitation, and acid reflux symptoms.
Faster and improved bioavailability compared to conventional PPIs.
Long half-life (approx. 18 hours) supports once-daily dosing.
Well tolerated with minimal side effects.
Dexlansoprazole suppresses gastric acid secretion by inhibiting the H⁺/K⁺-ATPase enzyme system at the gastric parietal cell level, offering reliable and long-lasting acid control.